AASLD 2025 7 - 10 November 2025

Weight-dependent and independent effects of semaglutide in participants with MASH: secondary analysis of the phase 3 ESSENCE trial

Authors :

Philip N. Newsome^1,2; Matthew J. Armstrong³; Igor Bakulin⁴; Adel Belloum⁵; Anja Geerts^6,7; Jacob George⁸; Ewa Janczewska⁹; Niels Krarup⁵; Chun-Jen Liu^10,11; Håvard Midgard¹²; Kwabena Opuni⁵; Vlad Ratziu¹³; Mary Rinella¹⁴; Michael Roden^15,16,17; Arun J. Sanyal¹⁸; Jörn Schattenberg¹⁹; Thea Vestergaard⁵; Elisabetta Bugianesi²⁰, on behalf of the ESSENCE Study Group

Affiliations

View Details Hide Details

Keywords

MASH

Congress oral presentation

GLP-1 RA

Semaglutide

PHASE 3 (RCT)

Search Science Hub

Are you a healthcare professional?

Weight-dependent and independent effects of semaglutide in participants with MASH: secondary analysis of the phase 3 ESSENCE trial